Evidence map›Paper›PMID 33598083›Full record

ArticleThe Pan African medical journal2020

[Epidemio-clinical features of retinoblastoma at the Yalgado Ouedraogo University Hospital Center in Burkina Faso: about 32 cases].

Paté Sankara, Windinmanégdé Pierre Djiguimde, Ahgbatouhabéba Ahnoux-Zabsonre, Jérôme Sanou, Gertrude Meda-Hien, Ibrahim Abib Diomande, Mariam Dolo-Traore, Jean Wenceslas Diallo, Gabrielle Chantal Bouda, Gaoussou Sidibe

Abstract readCase Reports
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paté SankaraCentre National de Lutte contre la Cécité, Ministère de la Santé, Ouagadougou, Burkina Faso.
Windinmanégdé Pierre DjiguimdeService d´Ophtalmologie, Centre Hospitalier Universitaire de Bogodogo, Ouagadougou, Burkina Faso.
Ahgbatouhabéba Ahnoux-ZabsonreService d´Ophtalmologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso.
Jérôme SanouService d´Ophtalmologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso.
Gertrude Meda-HienService d´Ophtalmologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso.
Ibrahim Abib DiomandeService d´Ophtalmologie, Centre Hospitalier Universitaire Bouaké, Université Alassane Ouattara, Bouaké, Côte d´Ivoire.
Mariam Dolo-TraoreService d´Ophtalmologie, Centre Hospitalier Universitaire Sourô Sanou, Bobo-Dioulasso, Burkina Faso.
Jean Wenceslas DialloService d´Ophtalmologie, Centre Hospitalier Universitaire Sourô Sanou, Bobo-Dioulasso, Burkina Faso.
Gabrielle Chantal BoudaService de Pédiatrie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso.
Gaoussou SidibeService d´Ophtalmologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinoblastoma is the most common intraocular cancer of childhood. Its estimated incidence is 1 case per 15 000 to 18 000 births. The purpose of this study is to highlight the epidemiological and clinical features of this disease as well as its management in Burkina Faso. We conducted a retrospective study over a period of 5 years at the Yalgado Ouedraogo University Hospital Center. The average age of patients was 33 months, with predominance of male sex (68.75%). Exophthalmia was the most frequent reason for consultation (59.37%). The predominant pattern was unilateral (75%) associated with eye protrusion (59.38%). Chemotherapy associated with surgery was the treatment of choice, with a 5-year survival rate of 34.37%. Retinoblastoma is one of the most common cancers in children younger than 5 years. In our low-income country this disease is diagnosed late. Patients´ management is complex and is commonly associated with poor prognosis. Mortality and morbidity from this disease are disproportionate in our country facing a shortage of technical equipment. In our low-income country, patient´s management should be based on early detection of the disease as well as on adequate treatment.

Indexed as

Antineoplastic AgentsBurkina FasoChildChild, PreschoolCombined Modality TherapyDelayed DiagnosisFemaleHospitals, UniversityHumansInfantMalePrognosisRetinal NeoplasmsRetinoblastomaRetrospective StudiesSurvival RateAntineoplastic AgentsBurkina FasocancerchemotherapychildRetinoblastomasurgery

Identifiers

PMID33598083
PMCPMC7864263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.